Product image of Teceris (Eribulin Mesylate Solution for Injection ) 0.5mg/ml x 2ml Vials supplied by GNH India

Teceris

Active Ingredient:
Eribulin Mesylate Solution for Injection
Form:
Vials
Brand:
Teceris
Origin:
Italy

Teceris (Eribulin Mesylate Solution for Injection Vials) 0.5mg/ml x 2ml

Teceris (Eribulin Mesylate) is a chemotherapy solution for injection used in cancer treatment. This 0.5mg/ml x 2ml vial provides a sterile, ready-to-use formulation. Store between 15-25°C and protect from light. Always follow healthcare provider instructions.

Strength

0.5mg/ml x 2ml

Pack Size

1s

Storage

15-25°

Manufacturer / TM Owner

BSP Pharmaceuticals S.p.A

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Teceris is primarily used to treat certain types of cancer, including metastatic breast cancer and liposarcoma. It belongs to a class of medications called microtubule inhibitors, which work by stopping cancer cells from dividing and growing. Patients often ask, 'what is Eribulin Mesylate used for' as part of cancer treatment protocols.

Side Effects

  • Teceris may cause common side effects such as fatigue, nausea, or low white blood cell counts. Some patients experience hair loss or changes in taste. These effects vary by individual and should be monitored by a healthcare professional. Always report persistent or severe reactions.

Precautions & Warnings

  • Handle Teceris with care as a cytotoxic agent; use gloves and protective clothing during preparation and administration. Avoid exposure to skin or mucous membranes. Keep vials refrigerated until use and discard unused portions properly. Follow local guidelines for hazardous waste disposal.

Avoid Interactions

  • Teceris may interact with medications that affect liver enzymes, such as strong CYP3A4 inhibitors or inducers. Alcohol and certain supplements may alter its effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Teceris (Eribulin Mesylate) is used to treat certain cancers, including metastatic breast cancer and liposarcoma.

Teceris is given as an intravenous injection by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, low white blood cell counts, and hair loss.

Teceris requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Store Teceris vials between 15-25°C and protect from light until ready for use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.